from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0057/-

LFCtreatmentdescriptionclass of inhibitor

1.002

Amikacinug/mL Amikacintranslation

1.567

Cap5-10ug/mL Capreomycintranslation

0.921

Rox10-50 ug/mL Roxithromycintranslation

-0.028

SM2-5 ug/mL Streptomycintranslation

0.411

Tet5-10 ug/mL Tetracyclinetranslation

-0.154

Rif0.2-5ug/mL Rifampicintranscription

0.624

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.005

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.025

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.320

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.637

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.658

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.397

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.911

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.535

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.221

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.353

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.280

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.270

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.046

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.286

KCN5-20 ug/mL Potassium cyaniderespiration

-0.253

NaN30.2-2 mM Sodium aziderespiration

0.127

Nigericin50 uM Nigericinrespiration

-0.171

TRC10-150 ug/mL Triclosanrespiration

-0.975

TRZ10-25 ug/mL Thioridazinerespiration

-1.029

Valinomycin0.5-10 uM Valinomycinrespiration

-0.528

ZnSO42 mM ZnSO4respiration

-0.015

menadione6-10 ug/mL Menadionerespiration

-0.890

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.937

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.400

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.145

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.925

NRP_1Non-replicating persistence stage 1dosRassociated

0.193

Amp0.2mg/mL AmpicillincellWall

0.344

Cephalexin20-100 ug/mL CephalexincellWall

0.636

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.044

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.106

EMB10-20 ug/mL EthambutolcellWall

0.237

Eta12-40 ug/mL EthionamidecellWall

0.533

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.435

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.961

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.684

BZA0.12 mg/mL BenzamidearomaticAmides

0.544

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.456

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.637

H2O24 mM hydrogen peroxideDNAdamaging

1.844

Levo10 ug/mL LevofloxacinDNAdamaging

0.471

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.024

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.659

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.158

UVUV-irradiationDNAdamaging

-0.098

ARP41-4 ug/mL Antitubercular compound ARP4?

0.919

Antimycin12.5-50 ug/mL Antimycin A?

0.493

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.113

PA_110-50 ug/mL Antitubercular compound PA-1?

0.430

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.239

PA8240.2-2 ug/mL PA-824?

-1.236

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.098

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.211

Verapamil50 uM Verapamil?

0.418

mercaptoethanol2 mM 2-Mercaptoethanol?

0.620

methoxatin10-20 ug/mL Methoxatin?